";s:4:"text";s:4960:" NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces that during July 2020, the Company retired approximately $3.3 million of debt, strengthening the Company’s balance sheet. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Want to see which stocks are moving? Learn everything you need to know about successful options trading with this three-part video course.Looking for new stock ideas?
NeuroOne Medical Technologies Corporation, an early-stage medical technology company, focuses on the development and commercialization of thin film electrode technology.
He's boiled down what's happening in the markets to just two words. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Neuroone Medical Technologies' stock was trading at $2.13 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. All rights reserved. View our full suite of financial calendars and market data tables, all for free.Receive a free world-class investing education from MarketBeat.
Q&A about "NMTC" projections. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable.
They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. The company is based in Eden Prairie, Minnesota.Neuroone Medical Technologies' management team includes the following people: Former hedge fund manager slams Wall Street in viral videoOne bold former hedge fund manager just went on camera to expose how Wall Street is failing American investors right now.
Neuroone Medical Technologies Co (NMTC) Analyst Forecast Next 12 months Current Price $2.20 52-week High $3.80 52-week Low $1.21 No Forecast Data Available for NMTC Last Price $2.20 You’re not going to see the details of what he's predicting anywhere in the news, especially not from the big banks on Wall Street.
All rights reserved. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. See what's happening in the market right now with MarketBeat's real-time news feed.